Health Care/Hospital

Samsung Biologics launches S-CHOice cell line expression technology

INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today held an online ceremony to announce the launch of its proprietary cell line technology, S-CHOice. Samsung Biologics Pro...

2020-08-05 09:09 1332

COVID-19 and heightened attention to racism affect Australian workers' mental health and relationships

Morneau Shepell's Mental Health Index™ remains steady in July at 12 points below the pre-pandemic benchmark of 75  MELBOURNE, Australia, Aug. 5, 2020 /PRNewswire/ -- Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its month...

2020-08-05 06:00 996

Colorcon Opens New Technical Centre in Melbourne, Australia to support the growing local pharmaceutical industry

HARLEYSVILLE, Penn., Aug. 5, 2020 /PRNewswire/ -- Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces the opening of a new technical center inMelbourne, Australia. The facility provides customers in Australasia access to pharmaceutical cl...

2020-08-05 05:00 1677

HealthEngine Releases Report on the Uptake of Telehealth in Australia

PERTH, Australia, Aug. 5, 2020 /PRNewswire/ -- While COVID-19 served as a catalyst for the uptake of telehealth, a new report from HealthEngine provides a snapshot of the early telehealth experience from acrossAustralia and the opportunities ahead. As the leading healthcare and telehealth destina...

2020-08-05 03:06 1613

The Point-of-Care Ultrasound Certification Academy announces Doctors Without Borders as MissionPOCUS selection for 2020

ROCKVILLE, Maryland, Aug. 5, 2020 /PRNewswire/ -- The Point-of-Care Ultrasound Certification Academy™ is announcing Médecins Sans Frontières (MSF), also known as Doctors Without Borders, as the selection of their MissionPOCUS™ project for the 2020 fiscal year. As the third MissionPOCUS project si...

2020-08-05 01:04 1559

Cordico Announces Exclusive Partnership With 'Emotional Survival' Author Dr. Kevin Gilmartin

Cordico is the exclusive technology partner of famous speaker and bestselling author of 'Emotional Survival for Law Enforcement: A Guide for Officers and Their Families' GOLD RIVER, California, Aug 4, 2020 /PRNewswire/ -- Cordico is proud to announce an exclusive partnership with Dr.Kevin Gilmar...

2020-08-04 22:00 1520

China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone Deficiency

SHANGHAI and GAITHERSBERG, Md., Aug. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the China National Medical Products Administration (...

2020-08-04 20:17 5700

Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, Extending the Cooperation since 2017

SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced the renewal of contract with Johnson & Jo...

2020-08-04 19:27 1570

KCI Plays an Important Role in Changing Public Transport Culture During COVID-19 Pandemic

JAKARTA, Indonesia, Aug. 4, 2020 /PRNewswire/ -- PT Kereta Commuter Indonesia (KCI), the operator for Commuter Line trains inIndonesia, is leading a cultural change in public transport during thisCOVID-19 global pandemic. As Indonesia transitions into new normal, KCI is providing a Commuter Lin...

2020-08-04 18:32 1697

WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor

SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it was awarded as "Most Honored Company" byInstitutional Investor , an international financial publication, based on the strength o...

2020-08-04 17:00 659

World Federation of Hemophilia (WFH) publishes "The WFH Guidelines for the Management of Hemophilia, 3rd edition"

MONTREAL, Aug. 4, 2020 /PRNewswire/ -- Led by content leads, Alok Srivastava, MD, andGlenn Pierce, MD, PhD, WFH Vice-President, Medical, this 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia offers up-to-date guidance and practical recommendation...

2020-08-04 17:00 1210

Panchshil Realty's Office Portfolio First in APAC To Meet British Safety Council's Global Benchmarks for COVID-19 Related Control Measures

PUNE, India, Aug. 4, 2020 /PRNewswire/ -- Panchshil Realty and British Safety Council today announced a new milestone in workplace safety in the corporate real estate sector inIndia in the context of COVID-19 and safe return to work. Panchshil Realty has become the first and only real estate gro...

2020-08-04 16:59 1319

AXA Hong Kong launches additional coverage for COVID-19

HONG KONG, Aug. 4, 2020 /PRNewswire/ -- In light of the ongoing spread of the Coronavirus Disease 2019 (COVID-19), AXA Hong Kong is now offering the following enhanced coverage and services to its customers to give them a peace of mind. New COVID-19 policy coverage and benefits, including: * ...

2020-08-04 16:30 1749

Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter

LAGUNA HILLS, California, Aug. 4, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of theintelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical re...

2020-08-04 10:16 1482

Amcor to report Full Year 2020 Results

ZURICH, Aug. 3, 2020 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its full year results for the twelve months ended30 June 2020 before the US market opens at3.00am US Eastern Daylight Time / 5.00 pm Australian Eastern Standard Time on Tuesday18 August 2020. A conference call a...

2020-08-04 10:06 6107

Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit

SEOUL, South Korea, Aug. 4, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee), announced on the 3rd that it had obtained the CE marking forEurope's In-Vitro Diagnostic (CE-IVD) devices for its coronavirus disease 2019 (COVID-19) test kit 'Axen™...

2020-08-04 10:00 1611

New data independently confirms and extends laboratory findings and expands safety profile of ATH434

MELBOURNE, Australia and SAN FRANCISCO, Aug. 3, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for present...

2020-08-04 09:33 5509

iHerb Announces Major Enhancement to iHerb's Popular Rewards Program

PASADENA, California, Aug. 4, 2020 /PRNewswire/ -- Global health and beauty e-commerce leader iHerb is revamping its Rewards Program to deliver better returns to loyal customers and those they refer to experience iHerb's superior line of products delivered at superior prices with superior service...

2020-08-04 04:55 1494

TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis

Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB PRETORIA, South Africa, Aug. 3, 2020 /PRNewswire/ -- Pretomanid, a novel compound...

2020-08-03 21:13 1610

PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC

DAEJEON, South Korea, Aug. 3, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to evaluate the combination of each party's clinical candidate, olinvacimab and C-005, a3rd generation of EGFR inhibitor with s...

2020-08-03 21:00 1213
12345 ... 866